Clinical Trial Update: Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of fluvastatin on certain markers in dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Lescol (fluvastatin)

Snippet

Sponsor: Novartis | Conditions: Dyslipidemia | Phase 4 | Status: COMPLETED